Carlos Henrique Gomes Martins Selected Research

Infections

12/2022	Potential in vitro anti-periodontopathogenic, anti-Chikungunya activities and in vivo toxicity of Brazilian red propolis.
11/2022	In vitro evaluation of the antibacterial and cytotoxic activities of the Euclea natalensis crude extract and fractions against oral infection agents.
11/2022	Antibacterial activity of Brazilian red propolis and in vitro evaluation of free radical production.
9/2020	Assessment of the antibacterial, antivirulence, and action mechanism of Copaifera pubiflora oleoresin and isolated compounds against oral bacteria.
6/2020	Antibacterial activity of salvia officinalis L. against periodontopathogens: An in vitro study.
4/2019	Susceptibility to Oral Antiseptics and Virulence Factors Ex Vivo Associated with Candida spp. Isolated from Dental Prostheses.
1/2018	In vitro studies of the antibacterial activity of Copaifera spp. oleoresins, sodium hypochlorite, and peracetic acid against clinical and environmental isolates recovered from a hemodialysis unit.
10/2017	Mikania glomerata Sprengel extract and its major compound ent-kaurenoic acid display activity against bacteria present in endodontic infections.
7/2016	Antifungal activity of plant-derived essential oils on Candida tropicalis planktonic and biofilms cells.
9/2011	Candida parapsilosis complex water isolates from a haemodialysis unit: biofilm production and in vitro evaluation of the use of clinical antifungals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Henrique Gomes Martins Research Topics

Disease

10	Infections 12/2022 - 09/2011
3	Dental Caries (Decay, Dental) 09/2020 - 07/2016
2	Mycoses (Diseases, Fungus) 01/2024 - 05/2007
2	Congenital Toxoplasmosis 01/2023 - 01/2020
2	Toxoplasmosis 08/2022 - 01/2020
2	Periodontitis 08/2022 - 01/2021
1	Bacterial Infections (Bacterial Infection) 08/2023
1	Communicable Diseases (Infectious Diseases) 08/2023
1	Cough 01/2023
1	Candidiasis (Moniliasis) 09/2022
1	Wounds and Injuries (Trauma) 05/2021
1	Inflammation (Inflammations) 12/2019
1	Oral Candidiasis (Thrush) 04/2019
1	Juvenile Amyotrophic Lateral Sclerosis 2 04/2019
1	Ulcer 01/2019
1	Leishmaniasis 01/2019
1	Neoplasms (Cancer) 01/2019
1	Renal Insufficiency (Renal Failure) 10/2018
1	Foodborne Diseases 09/2018
1	Denture Stomatitis 04/2016
1	Chronic Renal Insufficiency 01/2009
1	Halitosis 07/2008

Drug/Important Bio-Agent (IBA)

3	oleoresinsIBA 01/2021 - 09/2018
3	kaurenoic acidIBA 01/2019 - 07/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 06/2020
2	Sulfadiazine (Sulphadiazine)FDA Link 01/2023 - 01/2020
2	Pyrimethamine (Daraprim)FDA Link 01/2023 - 01/2020
2	DiterpenesIBA 01/2019 - 01/2019
1	rottlerinIBA 01/2024
1	neovestitolIBA 12/2022
1	vestitolIBA 12/2022
1	Complex MixturesIBA 11/2022
1	Propolis (Bee Bread)IBA 11/2022
1	Volatile Oils (Essential Oils)IBA 09/2022
1	Capsaicin (Zostrix)FDA Link 08/2022
1	Antiparasitic Agents (Antiparasitics)IBA 08/2022
1	ChalconesIBA 08/2022
1	SolutionsIBA 05/2021
1	hardwickic acidIBA 09/2020
1	manoolIBA 06/2020
1	Dental Implants (Dental Implant)IBA 12/2019
1	Peptide Hydrolases (Proteases)FDA Link 04/2019
1	Virulence Factors (Pathogenicity Factors)IBA 04/2019
1	dehydroabietic acidIBA 01/2019
1	Dialysis SolutionsIBA 10/2018
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 07/2016
1	linaloolIBA 07/2016
1	geraniol (nerol)IBA 07/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2011
1	PlasticsIBA 09/2011
1	N 30IBA 07/2008

Therapy/Procedure

4	Renal Dialysis (Hemodialysis) 10/2018 - 05/2007
2	Therapeutics 01/2018 - 07/2016
1	Traditional Medicine (Folk Remedies) 01/2023
1	Complementary Therapies (Alternative Medicine) 04/2019
1	Catheters 10/2018
1	Denture Liners 04/2016